Volume 61, Issue 6, Pages (June 2012)

Slides:

Advertisements

Similar presentations

Volume 18, Issue 9, Pages (September 2016)

Advertisements

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Volume 58, Issue 2, Pages (August 2010)

Laparoscopic Versus Open Radical Nephrectomy for Renal Cell Carcinoma: a Systematic Review and Meta-Analysis Gang Liu, Yulei Ma, Shouhua Wang, Xiancheng.

Volume 58, Issue 4, Pages (October 2010)

Volume 58, Issue 1, Pages (July 2010)

Single-Incision, Umbilical Laparoscopic versus Conventional Laparoscopic Nephrectomy: A Comparison of Perioperative Outcomes and Short-Term Measures of.

Volume 60, Issue 2, Pages (August 2011)

Dae Keun Kim, Dong Won Park, Koon Ho Rha European Urology

Volume 57, Issue 6, Pages (June 2010)

Volume 61, Issue 5, Pages (May 2012)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 69, Issue 1, Pages (January 2016)

European Urology Oncology

Volume 65, Issue 5, Pages (May 2014)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Volume 68, Issue 1, Pages (July 2015)

Volume 72, Issue 5, Pages (November 2017)

Prostate Cancer Epidemic in Sight?

Volume 71, Issue 4, Pages (April 2017)

Volume 63, Issue 1, Pages (January 2013)

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 54, Issue 4, Pages (October 2008)

Volume 54, Issue 4, Pages (October 2008)

Volume 73, Issue 2, Pages (February 2018)

Volume 61, Issue 5, Pages (May 2012)

Volume 52, Issue 5, Pages (November 2007)

Volume 61, Issue 4, Pages (April 2012)

Adjuvant Antiangiogenic Agents in Post-nephrectomy Renal Cell Carcinoma: A Systematic Review and Meta-analysis Mohamad B. Sonbol, Belal Firwana, Talal.

Volume 67, Issue 3, Pages (March 2015)

Volume 64, Issue 5, Pages (November 2013)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 68, Issue 1, Pages (July 2015)

Volume 63, Issue 5, Pages (May 2013)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 64, Issue 6, Pages (December 2013)

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

Volume 71, Issue 6, Pages (June 2017)

Volume 64, Issue 4, Pages (October 2013)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Volume 66, Issue 6, Pages (December 2014)

Volume 63, Issue 3, Pages (March 2013)

Volume 68, Issue 4, Pages (October 2015)

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

Volume 47, Issue 1, Pages (January 2005)

The Economic Costs of Overactive Bladder in Germany

Volume 53, Issue 1, Pages (January 2008)

Is Simple Enucleation a Minimal Partial Nephrectomy Responding to the EAU Guidelines’ Recommendations? Vincenzo Ficarra, Antonio Galfano, Stefano Cavalleri

Volume 50, Issue 5, Pages (November 2006)

Comparison of General Anesthesia and Conscious Sedation During Computed Tomography–Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma Hae Jin.

Volume 50, Issue 2, Pages (August 2006)

Testicular Cancer Variations in Time and Space in Europe

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Clinical Characteristics and Outcomes for Patients With Thymic Carcinoma: Evaluation of Masaoka Staging Anya M. Litvak, MD, Kaitlin Woo, MS, Sara Hayes,

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

European Urology is “Your” Journal

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Volume 53, Issue 6, Pages (June 2008)

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Annika Berntsen, Poul F. Geertsen, Inge Marie Svane European Urology

Jan Roigas European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 61, Issue 6, Pages 1156-1161 (June 2012) Radiofrequency Ablation Versus Partial Nephrectomy in Patients with Solitary Clinical T1a Renal Cell Carcinoma: Comparable Oncologic Outcomes at a Minimum of 5 Years of Follow-Up Ephrem O. Olweny, Samuel K. Park, Yung K. Tan, Sara L. Best, Clayton Trimmer, Jeffrey A. Cadeddu European Urology Volume 61, Issue 6, Pages 1156-1161 (June 2012) DOI: 10.1016/j.eururo.2012.01.001 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 Flowchart of included patients. NED=no evidence of disease; PN=partial nephrectomy; RCC=renal cell carcinoma; RFA=radiofrequency ablation. European Urology 2012 61, 1156-1161DOI: (10.1016/j.eururo.2012.01.001) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 2 (a) Overall survival and (b) cancer-specific survival for radiofrequency ablation (RFA) versus partial nephrectomy (PN). European Urology 2012 61, 1156-1161DOI: (10.1016/j.eururo.2012.01.001) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 3 Comparative (a) disease-specific survival, (b) local recurrence-free survival, and (c) metastasis-free survival for radiofrequency ablation (RFA) versus partial nephrectomy (PN). European Urology 2012 61, 1156-1161DOI: (10.1016/j.eururo.2012.01.001) Copyright © 2012 European Association of Urology Terms and Conditions